AMBIOPHARM, INC. Trademark

Trademark Overview

On Wednesday, April 7, 2021, a trademark application was filed for AMBIOPHARM, INC. with the United States Patent and Trademark Office. The USPTO has given the AMBIOPHARM, INC. trademark a serial number of 90628789. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by Ambio Pharmaceuticals. The AMBIOPHARM, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Pharmaceutical drug development services
ambiopharm, inc.

General Information

Serial Number90628789
Word MarkAMBIOPHARM, INC.
Filing DateWednesday, April 7, 2021
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6677054
Registration DateTuesday, March 22, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 1, "Pharrmaceuticals" should be deleted, and "Pharmaceuticals" should be inserted.
Pseudo MarkAMBIO PHARMACEUTICALS, INC.
NOT AVAILABLE"INC."
Goods and ServicesBiochemical research and development; Pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code042
First Use Anywhere DateThursday, March 31, 2005
First Use In Commerce DateThursday, March 31, 2005

Trademark Owner History

Party NameAmbio Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842
Party NameAmbio Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842
Party NameAmbio Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842

Trademark Events

Event DateEvent Description
Saturday, April 10, 2021NEW APPLICATION ENTERED
Monday, June 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 29, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 20, 2021ASSIGNED TO LIE
Wednesday, July 21, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, November 23, 2021ASSIGNED TO EXAMINER
Wednesday, December 1, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 1, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, December 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 1, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, December 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Monday, July 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 22, 2023TEAS SECTION 7 REQUEST RECEIVED
Wednesday, May 24, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 29, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 16, 2024POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, April 17, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, April 19, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, May 28, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

ambiopharm development services drug pharmaceutical biochemical research